Trials / Available
AvailableNCT05583604
Managed Access Programs for AIN457, Secukinumab
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this registration is to list Managed Access Programs (MAPs) related to AIN457, secukinumab
Detailed description
CAIN457M2002M - Available - Managed Access Program (MAP) Cohort Treatment Plan CAIN457M2002M to provide access to Secukinumab for adult and adolescent patients with Hidradenitis Suppurativa (HS)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | secukinumab | Patients receive secukinumab |
Timeline
- First posted
- 2022-10-18
- Last updated
- 2025-12-18
Source: ClinicalTrials.gov record NCT05583604. Inclusion in this directory is not an endorsement.